Jobs / United States / Novartis Pharmaceuticals Corporation
Director, Federal Government Affairs
Novartis Pharmaceuticals Corporation · 🇺🇸 Washington, DC
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Novartis Pharmaceuticals Corporation paid sponsored hires in similar roles23 certified filings for “Director, Forecasting-CV” (Data Scientists) in NJ: $170k–$170k, median $170k. Most were filed at wage level IV (83%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Novartis Pharmaceuticals Corporation
The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →
About the role
Job Description Summary The Director, Federal Government Affairs serves as a key representative and advocate for Novartis at the federal level, building and maintaining strategic relationships across Congress, the Administration, federal agencies, industry associations, and the broader healthcare policy community. The Director will develop and execute advocacy strategies that advance enterprise priorities, shape policy outcomes, and support the company's business objectives. The role provides strategic counsel to senior leadership on legislative and regulatory developments, drives engagement with external stakeholders and trade organizations, and helps strengthen Novartis' reputation as a trusted, innovative, and influential voice in healthcare policy. This role is based out of our Washington D.C. office 3x/week. Job Description Key responsibilities: • Provide respected, credible and active day-to-day representation of Novartis in Washington, D.C. by establishing and maintaining a strong, sophisticated network of relationships on Capitol Hill, within the Executive Branch, and relevant agencies and across the broader healthcare/policy community. • Proactively support the company’s enterprise priorities through strategic alignment of business priorities with the company’s advocacy and political agenda, including healthcare, tax, and workforce issues. • Lead the creation and execution of specific government affairs strategies to ensure an in-creased understanding of the company with respect to its strategic positioning in the industry, and build the company’s reputation for high integrity, competitive leadership and sustained performance. • Develop a strategic direction as it relates to the company’s outreach and engagement with federal government officials, issue management, and third parties. • Analyze legislative language; prepare and provide executive summaries of complex legislation and assist other NVS functions with issues involving federal officials. • Drive federal advocacy agenda and provide input/recommendations at key associations such as PhRMA, BIO, and others that impact policy development and strategy. • Manage expectation of Public Affairs leadership – keeping all relevant stakeholders informed on existent and upcoming federal legislative issues, delivering strategies for success and executing against those strategies. Essential Requirements: • 10+ years of experience with federal legislative, executive and public policy-making activities preferred. • Understanding of the healthcare and pharmaceutical industries and/or tax preferred. • In-depth knowledge of the U.S. legislative process, including an under-standing of the roles and decision-making processes of the Executive Agencies, the U.S. Senate, and U.S. House of Representatives. • Strong background in analyzing legislative language and providing strategic insights to support company functions involving federal officials. • Excellent communication skills to effectively represent the company in meetings and discussions with federal policymakers and stakeholders. • Proficiency in utilizing data-driven impact assessments to inform decision-making and policy development. Benefits & Rewards The salary for this position is expected to range between $176,400 and $327,600 per year. The final salary offered is determined based on factors like, but not limited to, relevant skills and experience, and upon joining Novartis will be reviewed periodically. Novartis may change the published salary range based on company and market factors. Your compensation will include a performance-based cash incentive and, depending on the level of the role, eligibility to be considered for annual equity awards. US-based eligible employees will receive a comprehensive benefi